Select Page

About GTP Bioways

GTP Bioways is an expert and fast-growing contract development and manufacturing organization (CDMO) specialised in process development and manufacturing of antibodies, proteins, bioconjugates and nanodrugs.

Our history

GTP Bioways is born out of the integration of several companies under one roof. It is their complementary expertise and long-standing experience in providing customised services to the biopharma industry that make our strength.

Today, with a team of almost 100 dedicated collaborators, GTP Bioways is focused on providing end-to-end services to support our customers at all stages of their drug development, from R&D to commercial manufacturing.

GTP Bioways CDMO - Cell line development for Bioconjugates

Expert & flexible CDMO for biologics, antibody conjugates and nanodrugs

GTP Bioways is a customer-centric and science-driven CDMO committed to offering uniquely customised process development and GMP manufacturing services for biologics, antibody-drug conjugates and nanodrugs.

With our cutting-edge facilities located in France, GTP Bioways can support biopharma companies from preclinical to commercial production of their innovative therapies.

Drawing on its expertise in solving difficult client problems, our team strives to offer a tailored approach, finely tuned to overcome your specific challenges. We are unique in our ability to develop agile solutions for challenging projects such as the production of difficult-to-express proteins, the development of atypical purification schemes or the formulation of nano-enabled products (NEP).

GTP Bioways CDMO - Cell line development for Bioconjugates
Cell line Development process

A science-driven and customer-centric CDMO

We are very proud of our teams of seasoned and highly qualified professionals and their extensive technical experience across all stages of the biopharmaceutical value chain, from R&D to cGMP production including aseptic filling.

Infusing a client-first corporate culture is a major priority of GTP Bioways’ management. We believe that empathy, integrity and transparency are key to ensuring long-lasting relationships with our customers and to the success of their programmes. We are proud to say that our customers praise our synergic approach.

Management team

The GTP Bioways management team and all GTP Bioways collaborators have a strong background in the development and manufacturing of innovative therapies.
Alain SAINSOT

Alain SAINSOT

President

Eric DEVIC

Eric DEVIC

Managing Director

Damien TOURNIER

Damien TOURNIER

Chief Financial Officer

    Hervé GINISTY

    Hervé GINISTY

    Chief Scientific Officer

    Vincent RIVERA

    Vincent RIVERA

    Director of BU Immuno

    Séverine HOUNTONDJI

    Séverine HOUNTONDJI

    Director of business development and marketing

    Carine ARCENS

    Carine ARCENS

    Corporate Quality Director

    From R&D to commercial production: our expertise spans all stages of biotherapeutics development

    Years as a CDMO

    Years' expertise in aseptic filling

    Clients served worldwide

    Protein programmes managed

    Discover more about GTP Bioways services

    GTP Bioways

    Our facilities

    GTP Bioways

    Our approach

    GTP Bioways

    Our references